Physician
Raymond S Nanko MD
Raymond S Nanko MD was paid $419.96 by Medicaid between Mar 2020 and Jul 2020, across 4 billing codes. Its largest line is 99213, doctor's office visit, returning patient (routine) — 57% of everything it billed.
33Billing provider infoRAYMOND S NANKO MD
MUNCIE, IN 47305
MUNCIE, IN 47305
33aNPI1922362334assigned 06/29/2012
33bProvider typeInterventional Pain Medicine Physician
28Total paid$419.96
24GClaims199
24DCodes billed4
24AFirst – last monthMar 2020 – Jul 2020
Compared with peers
Next to other Interventional Pain Medicine Physician providers in Indiana
Rank by total paid#11 of 17
Median peer was paid$3K
This provider vs. median0.1×
Peers share this provider's primary NPPES type and state. Size alone says nothing about billing quality: a big agency or a hospital system is expected to sit far above the median.
Box 24A · Dates of service
Paid by month
Paid that monthNov–Dec 2024: claims still arriving when the file was cut, so these months run low for every provider
By year, as a table
| Year | Claims | Paid | |
|---|---|---|---|
| 2020 | 199 | $419.96 |
Box 24 · Service lines
What it billed for
| Code | Service | Share | Claims | Bene. records | Paid |
|---|---|---|---|---|---|
| 99213 | Doctor's office visit, returning patient (routine)Office or other outpatient visit for the evaluation and management of an established patient, low complexity | 57% | 94 | 80 | $241.30 |
| 80307 | Drug test(s), presumptive, any number of drug classes; immunoassay | 38% | 48 | 40 | $161.59 |
| 80306 | 4.1% | 14 | 13 | $17.07 | |
| G0480 | Drug test(s), definitive, utilizing (1) drug identification methods able to identify individual drugs and distinguish between structural isomers (but not necessarily stereoisomers), including, but not limited to gc/ms (any type, single or tandem) and lc/ms (any type, single or tandem and excluding immunoassays (e.g., ia, eia, elisa, emit, fpia) and enzymatic methods (e.g., alcohol dehydrogenase)), (2) stable isotope or other universally recognized internal standards in all samples (e.g., to control for matrix effects, interferences and variations in signal strength), and (3) method or drug-specific calibration and matrix-matched quality control material (e.g., to control for instrument variations and mass spectral drift); qualitative or quantitative, all sources, includes specimen validity testing, per day; 1-7 drug class(es), including metabolite(s) if performed | 0% | 43 | 38 | $0.00 |
Claims and beneficiary counts add up across code × month rows, so one patient seen every month counts many times. Rows with fewer than 12 claims are suppressed by HHS, so small lines can be missing.
From NPPES
Who's on the registration
Authorized officialNANKO, RAYMOND (OWNER)